Jentashapir Journal of Health Research

Published by: Kowsar

Cranberry Supplement and Metabolic Risk Factors in Obese and Overweight Females

Mohammad Hassan Eftekhari 1 , Mansoureh Allaei 1 , * , Shahdad Khosropanah 2 , Abdoreza Rajaeifard 3 and Zahra Sohrabi 1
Authors Information
1 Nutrition Department, School of Health and Nutrition, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Department of Cardiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Epidemiology Department, School of Health and Nutrition, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Jentashapir Journal of Health Research: June 01, 2016, 7 (3); e37255
  • Published Online: April 16, 2016
  • Article Type: Research Article
  • Received: February 20, 2016
  • Accepted: March 10, 2016
  • DOI: 10.17795/jjhr-37255

To Cite: Eftekhari M H, Allaei M, Khosropanah S, Rajaeifard A, Sohrabi Z. et al. Cranberry Supplement and Metabolic Risk Factors in Obese and Overweight Females, Jentashapir J Health Res. 2016 ;7(3):e37255. doi: 10.17795/jjhr-37255.

Abstract
Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Gharipour M, Bagheri A, Boshtam M, Rabiei M. Prevalence of metabolic syndrome among the adults of central of areas of Iran (as a part of Isfahan healthy heart study. J Birjand Univ Med Sci. 2006; 13(3): 56-63
  • 2. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian adults--a population study using modified ATP III criteria. Diabetes Res Clin Pract. 2003; 60(3): 199-204[PubMed]
  • 3. Sadrbafoghi SM, Salari M, Rafiee M, Namayandeh SM, Abdoli AM, Karimi M. Prevalence and criteria of metabolic syndrome in an urban population: Yazd Healthy Heart Project. Tehran Univ Med J (TUMJ). 2006; 64(10): 90-6
  • 4. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract. 2003; 61(1): 29-37[PubMed]
  • 5. Fakhrzadeh H, Ebrahimpour P, Pourebrahim R, Heshmat R, Larijani B. Metabolic Syndrome and its Associated Risk Factors in Healthy Adults: APopulation-Based Study in Iran. Metab Syndr Relat Disord. 2006; 4(1): 28-34[DOI][PubMed]
  • 6. Erlund I, Koli R, Alfthan G, Marniemi J, Puukka P, Mustonen P, et al. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr. 2008; 87(2): 323-31[PubMed]
  • 7. Pinto Mda S, Ghaedian R, Shinde R, Shetty K. Potential of cranberry powder for management of hyperglycemia using in vitro models. J Med Food. 2010; 13(5): 1036-44[DOI][PubMed]
  • 8. Chambers BK, Camire ME. Can cranberry supplementation benefit adults with type 2 diabetes? Diabetes Care. 2003; 26(9): 2695-6[PubMed]
  • 9. Vattem DA, Ghaedian R, Shetty K. Enhancing health benefits of berries through phenolic antioxidant enrichment: focus on cranberry. Asia Pac J Clin Nutr. 2005; 14(2): 120-30[PubMed]
  • 10. Ruel G, Couillard C. Evidences of the cardioprotective potential of fruits: the case of cranberries. Mol Nutr Food Res. 2007; 51(6): 692-701[DOI][PubMed]
  • 11. Kim MJ, Jung HN, Kim KN, Kwak HK. Effects of cranberry powder on serum lipid profiles and biomarkers of oxidative stress in rats fed an atherogenic diet. Nutr Res Pract. 2008; 2(3): 158-64[DOI][PubMed]
  • 12. Wilson T, Singh AP, Vorsa N, Goettl CD, Kittleson KM, Roe CM, et al. Human glycemic response and phenolic content of unsweetened cranberry juice. J Med Food. 2008; 11(1): 46-54[DOI][PubMed]
  • 13. Neto CC. Cranberry and blueberry: evidence for protective effects against cancer and vascular diseases. Mol Nutr Food Res. 2007; 51(6): 652-64[DOI][PubMed]
  • 14. Ruel G, Pomerleau S, Couture P, Lemieux S, Lamarche B, Couillard C. Favourable impact of low-calorie cranberry juice consumption on plasma HDL-cholesterol concentrations in men. Br J Nutr. 2006; 96(2): 357-64[PubMed]
  • 15. Shidfar F, Heydari I, Hajimiresmaiel SJ, Hosseini S, Shidfar S, Amiri F. The effects of cranberry juice on serum glucose, apoB, apoA-I, Lp(a), and Paraoxonase-1 activity in type 2 diabetic male patients. J Res Med Sci. 2012; 17(4): 355-60[PubMed]
  • 16. Basu A, Betts NM, Ortiz J, Simmons B, Wu M, Lyons TJ. Low-energy cranberry juice decreases lipid oxidation and increases plasma antioxidant capacity in women with metabolic syndrome. Nutr Res. 2011; 31(3): 190-6[DOI][PubMed]
  • 17. van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord. 1993; 17(4): 187-96[PubMed]
  • 18. Salehi M, Sohrabi Z, Ekramzadeh M, Fallahzadeh MK, Ayatollahi M, Geramizadeh B, et al. Selenium supplementation improves the nutritional status of hemodialysis patients: a randomized, double-blind, placebo-controlled trial. Nephrol Dial Transplant. 2013; 28(3): 716-23[DOI][PubMed]
  • 19. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003; 35(8): 1381-95[DOI][PubMed]
  • 20. Azadbakht L, Surkan PJ, Esmaillzadeh A, Willett WC. The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients. J Nutr. 2011; 141(6): 1083-8[DOI][PubMed]
  • 21. Hinderliter AL, Babyak MA, Sherwood A, Blumenthal JA. The DASH diet and insulin sensitivity. Curr Hypertens Rep. 2011; 13(1): 67-73[DOI][PubMed]
  • 22. Azadbakht L, Fard NR, Karimi M, Baghaei MH, Surkan PJ, Rahimi M, et al. Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial. Diabetes Care. 2011; 34(1): 55-7[DOI][PubMed]
  • 23. Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos. 1991; 19(1): 100-6[PubMed]
  • 24. Wilson T, Meyers SL, Singh AP, Limburg PJ, Vorsa N. Favorable glycemic response of type 2 diabetics to low-calorie cranberry juice. J Food Sci. 2008; 73(9)-5[DOI][PubMed]
  • 25. Vinson JA, Bose P, Proch J, Al Kharrat H, Samman N. Cranberries and cranberry products: powerful in vitro, ex vivo, and in vivo sources of antioxidants. J Agric Food Chem. 2008; 56(14): 5884-91[DOI][PubMed]
  • 26. Ruel G, Pomerleau S, Couture P, Lamarche B, Couillard C. Changes in plasma antioxidant capacity and oxidized low-density lipoprotein levels in men after short-term cranberry juice consumption. Metabolism. 2005; 54(7): 856-61[DOI][PubMed]
  • 27. Apostolidis E, Kwon YI, Shetty K. Potential of cranberry-based herbal synergies for diabetes and hypertension management. Asia Pac J Clin Nutr. 2006; 15(3): 433-41[PubMed]
  • 28. Kahlon TS, Smith GE. In vitro binding of bile acids by blueberries, plums, prunes, strawberries, cherries, cranberries and apples. Food Chem. 2007; 100: 1182-7
  • 29. Kalgaonkar S, Gross HB, Yokoyama W, Keen CL. Effects of a flavonol-rich diet on select cardiovascular parameters in a Golden Syrian hamster model. J Med Food. 2010; 13(1): 108-15[DOI][PubMed]
  • 30. Charlton-Menys V, Betteridge DJ, Colhoun H, Fuller J, France M, Hitman GA, et al. Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS). Diabetologia. 2009; 52(2): 218-25[DOI][PubMed]
  • 31. Conen D, Rexrode KM, Creager MA, Ridker PM, Pradhan AD. Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: a prospective study. Circulation. 2009; 120(12): 1041-7[DOI][PubMed]
  • 32. Eckel RH. The Metabolic Syndrome. Harrison̛s principles of interal medicine. 2012; : 1550
  • 33. Vinson JA, Su X, Zubik L, Bose P. Phenol antioxidant quantity and quality in foods: fruits. J Agric Food Chem. 2001; 49(11): 5315-21[PubMed]
  • 34. McKay DL, Blumberg JB. Cranberries (Vaccinium macrocarpon) and cardiovascular disease risk factors. Nutr Rev. 2007; 65(11): 490-502[PubMed]
  • 35. Li C, Gu Q. Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy. Nephrology (Carlton). 2009; 14(5): 514-20[DOI][PubMed]
  • 36. Connelly PW, Zinman B, Maguire GF, Mamakeesick M, Harris SB, Hegele RA, et al. Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes. J Lipid Res. 2009; 50(6): 1216-22[DOI][PubMed]
  • 37. Getz GS, Reardon CA. Paraoxonase, a cardioprotective enzyme: continuing issues. Curr Opin Lipidol. 2004; 15(3): 261-7[PubMed]
  • 38. Jacobs M, van Greevenbroek MM, van der Kallen CJ, Ferreira I, Blaak EE, Feskens EJ, et al. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study. Eur J Clin Invest. 2009; 39(6): 437-44[DOI][PubMed]
  • 39. Huang Y, Nikolic D, Pendland S, Doyle BJ, Locklear TD, Mahady GB. Effects of cranberry extracts and ursolic acid derivatives on P-fimbriated Escherichia coli, COX-2 activity, pro-inflammatory cytokine release and the NF-kappabeta transcriptional response in vitro. Pharm Biol. 2009; 47(1): 18-25[DOI][PubMed]
  • 40. Williams K, Tchernof A, Hunt KJ, Wagenknecht LE, Haffner SM, Sniderman AD. Diabetes, abdominal adiposity, and atherogenic dyslipoproteinemia in women compared with men. Diabetes. 2008; 57(12): 3289-96[DOI][PubMed]
  • 41. Canoui-Poitrine F, Luc G, Bard JM, Ferrieres J, Yarnell J, Arveiler D, et al. Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study. Cerebrovasc Dis. 2010; 30(3): 252-9[DOI][PubMed]
  • 42. Sierra-Johnson J, Fisher RM, Romero-Corral A, Somers VK, Lopez-Jimenez F, Ohrvik J, et al. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population. Eur Heart J. 2009; 30(6): 710-7[DOI][PubMed]
  • 43. Thompson A, Danesh J. Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies. J Intern Med. 2006; 259(5): 481-92[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments